GP-Act III Acquisition (Nasdaq:GPAT) - Stock Price, News & Analysis

GPAT Stock Overview

Focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

About the company

GPAT fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	3/6
Financial Health	2/6
Dividends	0/6

Rewards

Became profitable this year

Risk Analysis

Makes less than USD$1m in revenue ($0)

GP-Act III Acquisition Corp. Competitors

ASA Gold and Precious Metals

NYSE:ASA

US$362.8m

FRMO

OTCPK:FRMO

US$323.6m

Saratoga Investment

NYSE:SAR

US$328.2m

Nabors Energy Transition II

NasdaqGM:NETD

US$405.3m

Price History & Performance

Summary of all time highs, changes and price drops for GP-Act III Acquisition
Historical stock prices
Current Share Price	US$10.02
52 Week High	US$10.06
52 Week Low	US$9.98
Beta	0
11 Month Change	0.10%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	0.30%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	GPAT	US Capital Markets	US Market
7D	-0.4%	-1.0%	-1.4%
1Y	n/a	30.3%	21.1%

Return vs Industry: Insufficient data to determine how GPAT performed against the US Capital Markets industry.

Return vs Market: Insufficient data to determine how GPAT performed against the US Market.

Price Volatility

Is GPAT's price volatile compared to industry and market?
GPAT volatility
GPAT Average Weekly Movement	0.3%
Capital Markets Industry Average Movement	4.1%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: GPAT has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine GPAT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2020	n/a	Antonio Carlos Augusto Bonchristiano	www.gp-act3.com

GP-Act III Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. GP-Act III Acquisition Corp. was incorporated in 2020 and is based in New York, New York.

GP-Act III Acquisition Corp. Fundamentals Summary

How do GP-Act III Acquisition's earnings and revenue compare to its market cap?
GPAT fundamental statistics
Market cap	US$359.91m
Earnings (TTM)	US$1.70m
Revenue (TTM)	n/a

212.0x

P/E Ratio

0.0x

P/S Ratio

Is GPAT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GPAT income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	-US$1.70m
Earnings	US$1.70m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.047
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.1%

How did GPAT perform over the long term?

See historical performance and comparison